Cytokine levels in serum of patients with juvenile rheumatoid arthritis

Citation
M. Yilmaz et al., Cytokine levels in serum of patients with juvenile rheumatoid arthritis, CLIN RHEUMA, 20(1), 2001, pp. 30-35
Citations number
28
Categorie Soggetti
Rheumatology
Journal title
CLINICAL RHEUMATOLOGY
ISSN journal
07703198 → ACNP
Volume
20
Issue
1
Year of publication
2001
Pages
30 - 35
Database
ISI
SICI code
0770-3198(2001)20:1<30:CLISOP>2.0.ZU;2-W
Abstract
We investigated serum levels of interleukin (IL)-1 beta, IL-6, IL-8, IL-12 and tumour necrosis factor (TNF)-alpha in JRA patients during both active a nd inactive phases of the disease. The systemic JRA patients had the highes t IL-1 beta and IL-6 levels during both active and inactive periods. In the systemic group IL-1 beta, IL-6 and IL-12 levels during the active period w ere elevated compared to the inactive period (p = 0.0173, p = 0.0359 and p = 0.0117, respectively). Levels of these cytokines during the inactive stag e were still greater than those of controls. IL-8 and TNF-alpha. levels dur ing both active and inactive periods were comparable to controls. IL-1 beta correlated strongly with CRP and ESR (p = 0.008 and p = 0.031, respectivel y). IL-6 correlated significantly with CRP (p = 0.002). IL-12 levels were f ound to be correlated with ESR and CRP (p = 0.03 and p = 0.04, respectively ). In active polyarticular JRA patients, IL-6 levels were elevated compared to the inactive phase, and the control (p = 0.001) IL-12 levels decreased significantly with clinical remission (p = 0.018). There was a strong corre lation between Il-12 levels and number of joint with limited motion (p = 0) . In oligoarticular JRA patients, IL-12 levels during active period were gr eater than in the controls and there was a marked decrease in IL-12 levels when the patients entered the inactive phase (p = 0.001) In conclusion, IL- 1 beta, IL-6 and IL-12 may play an important role in JRA and may be used as a marker of disease activity.